Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-19.72%
operating margin TTM
-0.54%
revenue TTM
343.84 Million
revenue per share TTM
1.65$
valuation ratios | |
|---|---|
| pe ratio | -18.28 |
| peg ratio | -0.62 |
| price to book ratio | -3.41 |
| price to sales ratio | 3.64 |
| enterprise value multiple | 100.49 |
| price fair value | -3.41 |
profitability ratios | |
|---|---|
| gross profit margin | 97.19% |
| operating profit margin | -0.54% |
| pretax profit margin | -19.29% |
| net profit margin | -19.72% |
| return on assets | -18.12% |
| return on equity | 18.75% |
| return on capital employed | -0.73% |
liquidity ratio | |
|---|---|
| current ratio | 2.63 |
| quick ratio | 2.58 |
| cash ratio | 0.65 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 232.82 |
| operating cycle | 296.86 |
| days of payables outstanding | 335.23 |
| cash conversion cycle | -38.37 |
| receivables turnover | 5.70 |
| payables turnover | 1.09 |
| inventory turnover | 1.57 |
debt and solvency ratios | |
|---|---|
| debt ratio | 1.65 |
| debt equity ratio | -1.70 |
| long term debt to capitalization | 2.49 |
| total debt to capitalization | 2.43 |
| interest coverage | -0.02 |
| cash flow to debt ratio | -0.06 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.26 |
| cash per share | 1.55 |
| operating cash flow per share | -0.25 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.06 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -46.64 |
Frequently Asked Questions
When was the last time BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) reported earnings?
BioCryst Pharmaceuticals, Inc. (BCRX) published its most recent earnings results on 05-11-2024.
What is BioCryst Pharmaceuticals, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)'s trailing twelve months ROE is 18.75%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. BioCryst Pharmaceuticals, Inc. (BCRX) currently has a ROA of -18.12%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did BCRX's net profit margin stand at?
BCRX reported a profit margin of -19.72% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is BCRX's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.63 in the most recent quarter. The quick ratio stood at 2.58, with a Debt/Eq ratio of -1.70.